Hear about what is happening in the pharmaceutical industry, including companies announcing business results, new products and mergers.

Industry News

Added 6 days ago Industry news

Abbott acquires Cephea Valve Technologies and mitral valve technology

Abbott announced that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company...

Added 15 days ago Industry news

Eli Lilly to acquire Loxo Oncology

Eli Lilly and Company and Loxo Oncology, Inc. announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00...

Added 19 days ago Industry news

BMS to acquire Celgene for approximately $74 billion.

Bristol-Myers Squibb Company and Celgene Corporation announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb...

Added 25 days ago Industry news

Boston Scientific acquires Millipede Inc. and with it Iris Transcatheter Annuloplasty Ring System

Boston Scientific Corporation announced it exercised its option to acquire the remaining shares of Millipede, Inc, a privately-held company in...

Added 1 month ago Industry news

Astellas Pharma acquires Potenza Therapeutics and immuno-oncology pipeline

Astellas Pharma announced that it exercised, and closed on its exclusive option to acquire Potenza Therapeutics, Inc. on December 13,...

Added 1 month ago Industry news

Mereo Biopharma to merge with OncoMed Pharma.

Mereo BioPharma Group plc, the clinical stage UK based biopharmaceutical company focused on rare diseases, and OncoMed Pharmaceuticals, Inc., a...

Added 1 month ago Industry news

GSK acquires TESARO and with it Zejula, a PARP inhibitor currently approved to treat Ovarian Cancer

GlaxoSmithKline plc and TESARO Inc announced that the companies have entered into a definitive agreement pursuant to which GSK will...

Added 1 month ago Industry news

Genetech/Roche acquires Jecure therapeutics and its preclinical portfolio of NLRP3 inhibitors a prospective treatment for NASH

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases,announced a definitive agreement by which...

Added 1 month ago Industry news

Alcon to become a stand alone company

Alcon, the eye care division of Novartis, will hold its first Capital Markets Day for investors and analysts in relation...

Added 1 month ago Industry news

Edge Therapeutics will merge with PDS Biotechnology Corporation.

Edge Therapeutics, Inc. and PDS Biotechnology Corporation, a privately-held, clinical-stage cancer immunotherapy company, announced today that their respective boards of...

Search all news articles